Search research articles
Contact Us
Filters
Showing results (11-20 of 21) with videos related to
Page
of 3
Sort By:
The Journal of Biological Chemistry
|
January 14, 2014
Crystal structure of interleukin-6 in complex with a modified nucleic acid ligand
Amy D Gelinas, Douglas R Davies, Thomas E Edwards, et al.
Plos One
|
April 18, 2012
Protein signature of lung cancer tissues
Michael R Mehan, Deborah Ayers, Derek Thirstrup, et al.
Frontiers in Microbiology
|
October 9, 2018
Optimization and Lead Selection of Benzothiazole Amide Analogs Toward a Novel Antimycobacterial Agent
Mary A De Groote, Thale C Jarvis, Christina Wong, et al.
The Journal of Biological Chemistry
|
January 14, 2014
Chemically modified DNA aptamers bind interleukin-6 with high affinity and inhibit signaling by blocking its interaction with interleukin-6 receptor
Shashi Gupta, Masao Hirota, Sheela M Waugh, et al.
Antimicrobial Agents and Chemotherapy
|
June 7, 2017
Safety, Tolerability, Systemic Exposure, and Metabolism of CRS3123, a Methionyl-tRNA Synthetase Inhibitor Developed for Treatment of Clostridium difficile, in a Phase 1 Study
Seema U Nayak, J McLeod Griffiss, Jeffrey Blumer, et al.
Antimicrobial Agents and Chemotherapy
|
November 6, 2019
Multiple-Ascending-Dose Phase 1 Clinical Study of the Safety, Tolerability, and Pharmacokinetics of CRS3123, a Narrow-Spectrum Agent with Minimal Disruption of Normal Gut Microbiota
Barbara K Lomeli, Hal Galbraith, Jared Schettler, et al.
Annals of the New York Academy of Sciences
|
August 3, 2023
Reimagining scientific conferences-a Keystone Symposia report
Shannon Weiman, Jennifer Cable, Walter Greenleaf, et al.
The Lancet. Infectious Diseases
|
January 25, 2026
Safety and efficacy of CRS3123 in adults with a primary episode or first recurrence of Clostridioides difficile infection: a phase 2, randomised, double-blind, multicentre, vancomycin-controlled study
Thomas Louie, Wendy Ribble, Louis Boccumini, et al.
Proceedings of the National Academy of Sciences of the United States of America
|
November 10, 2012
Unique motifs and hydrophobic interactions shape the binding of modified DNA ligands to protein targets
Douglas R Davies, Amy D Gelinas, Chi Zhang, et al.
Structure (London, England : 1993)
|
June 2, 2015
Non-helical DNA Triplex Forms a Unique Aptamer Scaffold for High Affinity Recognition of Nerve Growth Factor
Thale C Jarvis, Douglas R Davies, Akihiko Hisaminato, et al.
Page
of 3
Search research articles
Search
Showing results (11-20 of 21) with videos related to
Sort By:
Page
of 3
The Journal of Biological Chemistry
|
January 14, 2014
Crystal structure of interleukin-6 in complex with a modified nucleic acid ligand
Amy D Gelinas, Douglas R Davies, Thomas E Edwards, et al.
Plos One
|
April 18, 2012
Protein signature of lung cancer tissues
Michael R Mehan, Deborah Ayers, Derek Thirstrup, et al.
Frontiers in Microbiology
|
October 9, 2018
Optimization and Lead Selection of Benzothiazole Amide Analogs Toward a Novel Antimycobacterial Agent
Mary A De Groote, Thale C Jarvis, Christina Wong, et al.
The Journal of Biological Chemistry
|
January 14, 2014
Chemically modified DNA aptamers bind interleukin-6 with high affinity and inhibit signaling by blocking its interaction with interleukin-6 receptor
Shashi Gupta, Masao Hirota, Sheela M Waugh, et al.
Antimicrobial Agents and Chemotherapy
|
June 7, 2017
Safety, Tolerability, Systemic Exposure, and Metabolism of CRS3123, a Methionyl-tRNA Synthetase Inhibitor Developed for Treatment of Clostridium difficile, in a Phase 1 Study
Seema U Nayak, J McLeod Griffiss, Jeffrey Blumer, et al.
Antimicrobial Agents and Chemotherapy
|
November 6, 2019
Multiple-Ascending-Dose Phase 1 Clinical Study of the Safety, Tolerability, and Pharmacokinetics of CRS3123, a Narrow-Spectrum Agent with Minimal Disruption of Normal Gut Microbiota
Barbara K Lomeli, Hal Galbraith, Jared Schettler, et al.
Annals of the New York Academy of Sciences
|
August 3, 2023
Reimagining scientific conferences-a Keystone Symposia report
Shannon Weiman, Jennifer Cable, Walter Greenleaf, et al.
The Lancet. Infectious Diseases
|
January 25, 2026
Safety and efficacy of CRS3123 in adults with a primary episode or first recurrence of Clostridioides difficile infection: a phase 2, randomised, double-blind, multicentre, vancomycin-controlled study
Thomas Louie, Wendy Ribble, Louis Boccumini, et al.
Proceedings of the National Academy of Sciences of the United States of America
|
November 10, 2012
Unique motifs and hydrophobic interactions shape the binding of modified DNA ligands to protein targets
Douglas R Davies, Amy D Gelinas, Chi Zhang, et al.
Structure (London, England : 1993)
|
June 2, 2015
Non-helical DNA Triplex Forms a Unique Aptamer Scaffold for High Affinity Recognition of Nerve Growth Factor
Thale C Jarvis, Douglas R Davies, Akihiko Hisaminato, et al.
Page
of 3